4 D Molecular Therapeutics Inc (FDMT)

05:33 AM

Is 4D Molecular Therapeutics Inc. forming a reversal patternJuly 2025 Action & AI Enhanced Trading Alerts - Newser

05:33 AM

02:26 AM

Is 4D Molecular Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser

02:26 AM

Aug 13, 2025

4D Molecular Therapeutics’ SWOT analysis: gene therapy stock faces durability hurdles - Investing.com Australia

Aug 13, 2025

Aug 13, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Price Target Cut to $38.00 by Analysts at Roth Capital - Defense World

Aug 13, 2025

Aug 13, 2025

Can trapped investors hope for a rebound in 4D Molecular Therapeutics Inc.Market Activity Summary & AI Optimized Trading Strategy Guides - Newser

Aug 13, 2025

Aug 13, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Receives “Buy” Rating from Chardan Capital - Defense World

Aug 13, 2025

Aug 13, 2025

Can you recover from losses in 4D Molecular Therapeutics Inc.Risk Aware Trading Ideas with Alert Levels - Newser

Aug 13, 2025

Aug 12, 2025

What makes 4D Molecular Therapeutics Inc. stock price move sharplyRisk Aware Trading Ideas with Alert Levels - Newser

Aug 12, 2025

Aug 12, 2025

How 4D Molecular Therapeutics Inc. stock performs during market volatilityHigh Return Strategy with Low Risk - Newser

Aug 12, 2025

Aug 12, 2025

Using AI based signals to follow 4D Molecular Therapeutics Inc.Consistent Gain Plan with AI Support - Newser

Aug 12, 2025

Aug 12, 2025

Chardan Capital Raises PT on 4D Molecular to $25. - AInvest

Aug 12, 2025

Aug 12, 2025

4D Molecular Therapeutics Faces Revenue Challenges Amid Complex Reimbursement Landscape - TipRanks

Aug 12, 2025

Aug 12, 2025

Published on: 2025-08-12 01:26:37 - Newser

Aug 12, 2025

Aug 12, 2025

Will earnings trigger a reversal in 4D Molecular Therapeutics Inc.Free Pattern Breakout Entry Stock Forecast - Newser

Aug 12, 2025

Aug 12, 2025

4D Molecular Therapeutics Advances Clinical Programs in Q2 2025 - TipRanks

Aug 12, 2025

Aug 11, 2025

4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Misses Revenue Estimates - sharewise.com

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics Tightens Belt While Chasing FDA Approval - Finimize

Aug 11, 2025

Aug 11, 2025

Spectral Ai, Inc. shares rise 1.64% premarket after 4D Molecular Therapeutics reported positive 60-week results from 4D-150 SPECTRA clinical trial in DME. - AInvest

Aug 11, 2025

Aug 11, 2025

4d Molecular Therapeutics Posts Q2 2025 Revenue Surge of 200% to $15 Million - AInvest

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics: Is the Widening Net Loss Justified by the Promise of 4D-150 in Wet AMD? - AInvest

Aug 11, 2025

Aug 11, 2025

4dMT Revenue Jumps 200 Percent in Q2 - The Motley Fool

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics Reports Q2 GAAP EPS of -$0.98, Below Expectations - AInvest

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics Q2 net loss widens to $54.7 mln - MarketScreener

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics advances 4D-150 program, extends cash runway to 2028. - AInvest

Aug 11, 2025

Aug 11, 2025

4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewswire

Aug 11, 2025

Aug 11, 2025

4DMT Fast-Tracks Wet AMD Phase 3 Trial: Key Data Now Expected 6 Months Earlier Than Planned - Stock Titan

Aug 11, 2025

Aug 11, 2025

Developing predictive dashboards with 4D Molecular Therapeutics Inc. dataWeekly Entry Signal Based Forecast Tool - Newser

Aug 11, 2025

Aug 11, 2025

Volatility clustering patterns for 4D Molecular Therapeutics Inc.Free Swing Trade With Risk Management - Newser

Aug 11, 2025

Aug 11, 2025

Will 4D Molecular Therapeutics Inc. price bounce be sustainableFree Smart Money Tracking Signal Generator - Newser

Aug 11, 2025

Aug 11, 2025

4D Molecular Therapeutics Inc. stock prediction for this weekShort-Term Stock Trend Forecast Guide - Newser

Aug 11, 2025

Aug 11, 2025

Why 4D Molecular Therapeutics Inc. stock attracts strong analyst attentionMulti-Bagger Detection with Trend Tools - Newser

Aug 11, 2025

Aug 09, 2025

How to build a custom watchlist for 4D Molecular Therapeutics Inc.Free Price Action Based Buy Opportunity List - Newser

Aug 09, 2025

Aug 09, 2025

What technical models suggest about 4D Molecular Therapeutics Inc.’s comebackConsistent Gain Plan with AI Support - Newser

Aug 09, 2025

Aug 09, 2025

Technical analysis overview for 4D Molecular Therapeutics Inc. stockFree Portfolio Diversification Stock Ideas - Newser

Aug 09, 2025

Aug 09, 2025

Heatmap analysis for 4D Molecular Therapeutics Inc. and competitorsFree Momentum Based Equity Trading Plan - Newser

Aug 09, 2025

Aug 07, 2025

What makes 4D Molecular Therapeutics Inc. stock attractive to long term investorsFree Real Market Momentum Signal Generator - Newser

Aug 07, 2025

Aug 07, 2025

4D Molecular Therapeutics to Participate in H.C. Wainwright Ophthalmology Virtual Conference - AInvest

Aug 07, 2025

Aug 07, 2025

4D Molecular Therapeutics shares fall 1.92% premarket ahead of H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest

Aug 07, 2025

Aug 07, 2025

4D Molecular Therapeutics (FDMT) to Release Earnings on Thursday - Defense World

Aug 07, 2025

Aug 06, 2025

4D Molecular Therapeutics shares fall 2.73% intraday after announcing participation in H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest

Aug 06, 2025

Aug 06, 2025

4DMT's Strategic Ophthalmology Push: A Glimpse into the Future of Gene Therapy for Retinal Diseases - AInvest

Aug 06, 2025

Aug 05, 2025

Using fundamentals and technicals on 4D Molecular Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser

Aug 05, 2025

Aug 04, 2025

4D Molecular Therapeutics Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Aug 04, 2025